Olema Pharmaceuticals Inc... (OLMA)
NASDAQ: OLMA
· Real-Time Price · USD
8.48
0.29 (3.54%)
At close: Sep 26, 2025, 11:06 AM
3.54% (1D)
| Bid | 6.05 |
| Market Cap | 582.08M |
| Revenue (ttm) | 364K |
| Net Income (ttm) | -142.29M |
| EPS (ttm) | -1.97 |
| PE Ratio (ttm) | -4.31 |
| Forward PE | -3.9 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 10.71 |
| Volume | 261,349 |
| Avg. Volume (20D) | 786,696 |
| Open | 8.29 |
| Previous Close | 8.19 |
| Day's Range | 8.19 - 8.59 |
| 52-Week Range | 2.86 - 13.51 |
| Beta | 1.94 |
| Ex-Dividend Date | n/a |
About OLMA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OLMA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OLMA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+16.19%
Olema Pharmaceuticals shares are trading higher. T...
Unlock content with
Pro Subscription
9 months ago
+0.89%
Olema Pharmaceutical shares are trading higher after the company announced a new clinical trial collaboration and supply agreement with Novartis for frontline metastatic breast cancer. Also, the company entered into a private placement of common stock worth $250 million.
